Skip to main content
. 2011 Jan 25;6(1):e16475. doi: 10.1371/journal.pone.0016475

Figure 5. Endogenous anti-E. coli and anti-HSV activity following vaginal application of TFV and placebo gel.

Figure 5

The percentage inhibition of E. coli was determined relative to colonies formed on control plates treated with GTB (upper panel). Vero cells were infected with HSV-2(G) mixed 1∶1 with CVL or control buffer (lower panel). Results are presented as mean percentage inhibition of cfu or plaque forming units (pfu) ± SE. All samples were tested in duplicate in two independent experiments.